MEI Pharma Inc. [MEIP] moved up 2.39: Why It’s Important


MEI Pharma Inc. [NASDAQ: MEIP] closed the trading session at $0.65 on 06/27/22. The day’s price range saw the stock hit a low of $0.6002, while the highest price level was $0.6732. The company report on June 22, 2022 that MEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officer.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Anne Frese, an experienced industry executive, joined MEI as chief people officer, a role reporting to Daniel P. Gold, chief executive officer. Ms. Frese will be responsible for the strategy and processes related to building and retaining an exceptional team of professionals. Ms. Frese’s appointment is effective immediately.

Ms. Frese joins MEI with over 30 years of human resource experience across a variety of industries, including biotech, consulting, hospitality, and engineering. Most recently, she served as chief human resources officer at Vyripharm Enterprises. Previously, Ms. Frese’s experience includes serving as Vice President of Human Resources at Artiva Therapeutics and Bellicum Pharmaceuticals, Inc. She received a bachelor’s degree in Labor Relations and Economics from the McGill University.

The stocks have a year to date performance of -75.73 percent and weekly performance of 18.63 percent. The stock has been moved at -74.78 percent over the last six months. The stock has performed 55.38 percent around the most recent 30 days and changed 2.76 percent over the most recent 3-months.

If compared to the average trading volume of 7.87M shares, MEIP reached to a volume of 6176263 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about MEI Pharma Inc. [MEIP]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MEIP shares is $5.17 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MEIP stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wells Fargo have made an estimate for MEI Pharma Inc. shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on March 25, 2022. While these analysts kept the previous recommendation, Stifel dropped their target price from $6 to $2. The new note on the price target was released on March 25, 2022, representing the official price target for MEI Pharma Inc. stock. Previously, the target price had yet another drop from $4 to $1, while Jefferies kept a Hold rating on MEIP stock.

The Average True Range (ATR) for MEI Pharma Inc. is set at 0.06, with the Price to Sales ratio for MEIP stock in the period of the last 12 months amounting to 1.72. The Price to Book ratio for the last quarter was 1.27, with the Price to Cash per share for the same quarter was set at 1.31.

MEIP stock trade performance evaluation

MEI Pharma Inc. [MEIP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 18.63. With this latest performance, MEIP shares gained by 55.38% in over the last four-week period, additionally sinking by -74.78% over the last 6 months – not to mention a drop of -80.06% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MEIP stock in for the last two-week period is set at 61.91, with the RSI for the last a single of trading hit 70.01, and the three-weeks RSI is set at 54.26 for MEI Pharma Inc. [MEIP]. The present Moving Average for the last 50 days of trading for this stock 0.5333, while it was recorded at 0.6096 for the last single week of trading, and 1.8713 for the last 200 days.

MEI Pharma Inc. [MEIP]: An insightful look at the core fundamentals

MEI Pharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.70 and a Current Ratio set at 7.70.

Earnings per share (EPS) analysis for MEI Pharma Inc. [MEIP] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MEIP. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MEI Pharma Inc. go to -0.10%.

MEI Pharma Inc. [MEIP]: Insider Ownership positions

There are presently around $37 million, or 44.40% of MEIP stock, in the hands of institutional investors. The top three institutional holders of MEIP stocks are: NEA MANAGEMENT COMPANY, LLC with ownership of 8,533,072, which is approximately 0% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 6,867,423 shares of the stock with an approximate value of $4.35 million in MEIP stocks shares; and VANGUARD GROUP INC, currently with $3.95 million in MEIP stock with ownership of nearly 8.254% of the company’s market capitalization.

Positions in MEI Pharma Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 56 institutional holders increased their position in MEI Pharma Inc. [NASDAQ:MEIP] by around 6,458,259 shares. Additionally, 57 investors decreased positions by around 39,290,889 shares, while 17 investors held positions by with 13,021,045 shares. The mentioned changes placed institutional holdings at 58,770,193 shares, according to the latest SEC report filing. MEIP stock had 20 new institutional investments in for a total of 2,508,567 shares, while 35 institutional investors sold positions of 31,812,094 shares during the same period.